Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

  • There is currently no data for AFN

Trading Update

21 Jan 2020 07:30

RNS Number : 3877A
ADVFN PLC
21 January 2020
 

For immediate release

21 January 2020

 

ADVFN PLC

("ADVFN" or the "Company")

Trading update

 

The Board of ADVFN expects to publish its unaudited interim accounts for the six months ended 31 December 2019 (the first half) towards the end of March in line with the normal reporting timetable.

 

Sales during the first half were generally flat although sales overall were in the latter part of the first half below management's expectations. Registered users remained broadly constant at around 4.7 million. From time to time ADVFN has experienced similar variations in market conditions and has subsequently adjusted its cost base to accommodate them. Historically, the Company has always looked to grow by investing available capital into the development of the company and has previously reduced its operational cost base and level of investment to align it more closely with the market conditions. Given the lower level of sales in the first half (and in particular the period immediately leading up to Christmas) first half sales are estimated to have been approximately £3.6 million (2018: £4.3 million), reflected in an increased loss in the first half (compared to the first half in 2018). The Company is currently reducing its head count and the Board believes that this cost reduction will be reflected in an improved performance in the second half.

 

Clem Chambers said:

"While developments in the New Year have been positive, we are adjusting our cost base to accommodate a broader range of outcomes in 2020."

 

More information on ADVFN can be found at: www.ADVFN.com 

For further information please contact: 

 

 ADVFN PLC +44 (0) 207 070 0909

 Clem Chambers, CEO

 

 Beaumont Cornish Limited (Nominated Adviser)

 www.beaumontcornish.com 

+44 (0) 207 628 3396

 Roland Cornish/Michael Cornish

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEMEESESSEIF
Date   Source Headline
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company
4th Apr 202212:25 pmRNSNotice of GM
28th Mar 20228:04 amRNSCorporate Update
22nd Mar 20227:00 amRNSWinners of Financial Awards 2022 Announced
17th Mar 20223:32 pmRNSHolding(s) in Company
17th Mar 20223:32 pmRNSHolding(s) in Company
16th Mar 202210:29 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSCorporate Update
3rd Mar 20225:20 pmRNSCorporate Update
25th Feb 20222:02 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBoard change
23rd Feb 20227:00 amRNSCorporate Update
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 20229:21 amRNSRequisition of general meeting update
8th Feb 202210:54 amRNSStrategic review and end of formal sales process
3rd Feb 202210:47 amRNSForm 8.3 - ADVFN PLC
26th Jan 20221:15 pmRNSRequisition of General Meeting
26th Jan 20227:00 amRNSBest Global Private Investor Multi-Market Informat
24th Jan 20229:35 amRNSForm 8.3 - ADVFN plc
21st Jan 20223:14 pmRNSForm 8.3 - ADVFN plc
19th Jan 20225:03 pmRNSForm 8.3 - ADVFN plc
19th Jan 20224:53 pmRNSForm 8.3 - ADVFN PLC
18th Jan 20227:00 amRNSForm 8 (OPD) ADVFN plc
13th Jan 20227:00 amRNSStrategic review and formal sales process
29th Dec 20215:19 pmRNSHolding(s) in Company
29th Dec 20215:15 pmRNSHolding(s) in Company
23rd Dec 20213:28 pmRNSResult of AGM
22nd Nov 20211:08 pmRNSHolding(s) in Company - Replacement
22nd Nov 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.